In summary, we found that BGE exerts anti-inflammatory activity both in vitro and in vivo by reducing the activation of PKCθ and asthma-associated transcription factors (NFAT, NF-κB, STAT6, and GATA3). The gene discussed is PRRT2; the disease is asthma.